Dual targeting of TAM receptors Tyro3, Axl, and MerTK: Role in tumors and the tumor immune microenvironment

被引:1
作者
Wang, Kai-Hung [1 ]
Ding, Dah-Ching [2 ]
机构
[1] Hualien Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Med Res, Hualien, Taiwan
[2] Hualien Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Obstet & Gynecol, 707,Sect 3,Chung Yang Rd, Hualien, Taiwan
来源
TZU CHI MEDICAL JOURNAL | 2021年 / 33卷 / 03期
关键词
Axl; MerTK; Tyro3; and MerTK receptors; Tumor immune microenvironment; TYROSINE KINASE AXL; SMALL-MOLECULE INHIBITOR; THERAPEUTIC TARGET; GROWTH ARREST; EXPRESSION ANALYSIS; CANCER METASTASIS; BREAST-CANCER; LUNG-CANCER; CELL-GROWTH; C-MER;
D O I
10.4103/tcmj.tcmj_129_20
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In both normal and tumor tissues, receptor tyrosine kinases (RTKs) may be pleiotropically expressed. The RTKs not only regulate ordinary cellular processes, including proliferation, survival, adhesion, and migration, but also have a critical role in the development of many types of cancer. The Tyro3, Axl, and MerTK (TAM) family of RTKs (Tyro3, Axl, and MerTK) plays a pleiotropic role in phagocytosis, inflammation, and normal cellular processes. In this article, we highlight the cellular activities of TAM receptors and discuss their roles in cancer and immune cells. We also discuss cancer therapies that target TAM receptors. Further research is needed to elucidate the function of TAM receptors in immune cells toward the development of new targeted immunotherapies for cancer.
引用
收藏
页码:250 / 256
页数:7
相关论文
共 114 条
  • [11] An Epithelial-Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance
    Byers, Lauren Averett
    Diao, Lixia
    Wang, Jing
    Saintigny, Pierre
    Girard, Luc
    Peyton, Michael
    Shen, Li
    Fan, Youhong
    Giri, Uma
    Tumula, Praveen K.
    Nilsson, Monique B.
    Gudikote, Jayanthi
    Tran, Hai
    Cardnell, Robert J. G.
    Bearss, David J.
    Warner, Steven L.
    Foulks, Jason M.
    Kanner, Steven B.
    Gandhi, Varsha
    Krett, Nancy
    Rosen, Steven T.
    Kim, Edward S.
    Herbst, Roy S.
    Blumenschein, George R.
    Lee, J. Jack
    Lippman, Scott M.
    Ang, K. Kian
    Mills, Gordon B.
    Hong, Waun K.
    Weinstein, John N.
    Wistuba, Ignacio I.
    Coombes, Kevin R.
    Minna, John D.
    Heymach, John V.
    [J]. CLINICAL CANCER RESEARCH, 2013, 19 (01) : 279 - 290
  • [12] Natural killer cell differentiation driven by Tyro3 receptor tyrosine kinases
    Caraux, Anouk
    Lu, Qingxian
    Fernandez, Nadine
    Riou, Sylvain
    Di Santo, James P.
    Raulet, David H.
    Lemke, Greg
    Roth, Claude
    [J]. NATURE IMMUNOLOGY, 2006, 7 (07) : 747 - 754
  • [13] Targeting Axl With an High-affinity Inhibitory Aptamer
    Cerchia, Laura
    Esposito, Carla L.
    Camorani, Simona
    Rienzo, Anna
    Stasio, Loredana
    Insabato, Luigi
    Affuso, Andrea
    de Franciscis, Vittorio
    [J]. MOLECULAR THERAPY, 2012, 20 (12) : 2291 - 2303
  • [14] Axl and prostasin are biomarkers for prognosis of ovarian adenocarcinoma
    Chen, Pu-xiang
    Li, Qiao-yan
    Yang, Zhulin
    [J]. ANNALS OF DIAGNOSTIC PATHOLOGY, 2013, 17 (05) : 425 - 429
  • [15] Expression of the proto-oncogene Axl in renal cell carcinoma
    Chung, BI
    Malkowicz, SB
    Nguyen, TB
    Libertino, JA
    McGarvey, TW
    [J]. DNA AND CELL BIOLOGY, 2003, 22 (08) : 533 - 540
  • [16] MerTK inhibition in tumor leukocytes decreases tumor growth and metastasis
    Cook, Rebecca S.
    Jacobsen, Kristen M.
    Wofford, Anne M.
    DeRyckere, Deborah
    Stanford, Jamie
    Prieto, Anne L.
    Redente, Elizabeth
    Sandahl, Melissa
    Hunter, Debra M.
    Strunk, Karen E.
    Graham, Douglas K.
    Earp, H. Shelton, III
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (08) : 3231 - 3242
  • [17] RECEPTOR TYROSINE KINASES EXPRESSED IN METASTATIC COLON-CANCER
    CRAVEN, RJ
    XU, LH
    WEINER, TM
    FRIDELL, YW
    DENT, GA
    SRIVASTAVA, S
    VARNUM, B
    LIU, ET
    CANCE, WG
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1995, 60 (06) : 791 - 797
  • [18] Mertk on tumor macrophages is a therapeutic target to prevent tumor recurrence following radiation therapy
    Crittenden, Marka R.
    Baird, Jason
    Friedman, David
    Savage, Talicia
    Uhde, Lauren
    Alice, Alejandro
    Cottam, Benjamin
    Young, Kristina
    Newell, Pippa
    Nguyen, Cynthia
    Bambina, Shelly
    Kramer, Gwen
    Akporiaye, Emmanuel
    Malecka, Anna
    Jackson, Andrew
    Gough, Michael J.
    [J]. ONCOTARGET, 2016, 7 (48) : 78653 - 78666
  • [19] Molecular Pathways: MERTK Signaling in Cancer
    Cummings, Christopher T.
    DeRyckere, Deborah
    Earp, H. Shelton
    Graham, Douglas K.
    [J]. CLINICAL CANCER RESEARCH, 2013, 19 (19) : 5275 - 5280
  • [20] Mutations in MERTK, the human orthologue of the RCS rat retinal dystrophy gene, cause retinitis pigmentosa
    Gal, A
    Li, Y
    Thompson, DA
    Weir, J
    Orth, U
    Jacobson, SG
    Apfelstedt-Sylla, E
    Vollrath, D
    [J]. NATURE GENETICS, 2000, 26 (03) : 270 - 271